Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Medical Virology|August 9, 2020
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cellsMeehyun Ko, Sangeun Jeon, Wang-Shick Ryu, et al.Microbiology Spectrum|August 11, 2021
TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351)Jihye Lee, JinAh Lee, Hyeon Ju Kim, et al.Antimicrobial Agents and Chemotherapy|May 6, 2020
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved DrugsSangeun Jeon, Meehyun Ko, Jihye Lee, et al.Biorxiv : the Preprint Server for Biology|March 10, 2021
Published Anti-SARS-CoV-2 In Vitro Hits Share Common Mechanisms of Action that Synergize with AntiviralsJing Xing, Shreya Paithankar, Ke Liu, et al.Briefings in Bioinformatics|July 10, 2021
Published anti-SARS-CoV-2 in vitro hits share common mechanisms of action that synergize with antiviralsJing Xing, Shreya Paithankar, Ke Liu, et al.Angewandte Chemie (International Ed. in English)|August 12, 2024
Broad-Spectrum Antiviral Agents against SARS-CoV-2 Variants Inhibit the Conserved Viral Protein Nsp1-RNA InteractionWan Gi Byun, Minha Lee, Meehyun Ko, et al.Antimicrobial Agents and Chemotherapy|November 14, 2022
Lancemaside A from Codonopsis lanceolata: Studies on Antiviral Activity and Mechanism of Action against SARS-CoV-2 and Its Variants of ConcernTai Young Kim, Sangeun Jeon, Meehyun Ko, et al.Plos Pathogens|February 2, 2019
An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virusKi Hyun Kim, Jinhee Kim, Meehyun Ko, et al.Iscience|September 12, 2022
Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variantsJing Xing, Rama Shankar, Meehyun Ko, et al.Journal of Medical Virology|June 13, 2023
Novel SARS-CoV-2 entry inhibitors, 2-anilinoquinazolin-4(3H)-one derivatives, show potency as SARS-CoV-2 antivirals in a human ACE2 transgenic mouse modelMeehyun Ko, Jun Young Lee, Young Sup Shin, et al.Pageof 2